drugset / Trial / NCT00834743

Metformin ER 750 mg Tablets, Fasting

NCT00834743 ↗

Phase 1 Completed 32 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study is to compare the rate and extent of absorption of metformin from a test formulation of Metformin ER 750 mg Tablets versus the reference Glucophage® XR 750 mg Tablets under fasting conditions.

Timeline

Start
2003-08
Primary completion
2003-08
Completion
2003-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 750 mg —

Indications

No indication recorded.